Discover Psoriasis Treatment Options: A Clinical Overview

Discover psoriasis treatment options by comparing the main clinical approaches used to reduce plaques, scaling, itching, and inflammation. Psoriasis is a chronic, recurring inflammatory disease with no permanent cure, so treatment is generally focused on controlling symptoms, reducing flare activity, and improving quality of life. 1

How Psoriasis Treatment Is Selected

Psoriasis severity is an important starting point. One clinical framework describes disease affecting less than 3% of the body surface area as mild, 3% to 10% as moderate, and more than 10% as severe. Location also matters: scalp, nails, palms, soles, skin folds, and other high-impact areas can create substantial functional or quality-of-life effects even when the total area is limited. 3

Treatment planning may also account for psoriasis type, previous treatment response, lifestyle, other medical conditions, pregnancy considerations, and personal preferences. Psoriasis can occur in several forms, including plaque, guttate, inverse, and pustular psoriasis, and the most suitable therapy may differ by type and location. Combination treatment is sometimes used, but potential interactions and contraindications should be reviewed with healthcare professionals. 24

Topical Medicines for Localized Disease

Topical therapy applies medicine directly to affected skin and is commonly used for mild to moderate or localized psoriasis. Prescription corticosteroids can reduce redness, swelling, and inflammation. Other prescription options include vitamin D3 analogues, topical retinoids, calcineurin inhibitors, roflumilast, and tapinarof. These medicines may be supplied as creams, ointments, gels, foams, sprays, lotions, solutions, or shampoos, depending on the treatment and body site. 23

Over-the-counter products containing salicylic acid or coal tar may help with scale or symptoms, while fragrance-free moisturizers can soothe dry skin. Scalp psoriasis may require a shampoo, solution, foam, or other formulation that can reach hair-covered skin. Topical corticosteroids should be used according to professional instructions because treatment selection and duration depend on the affected area and clinical circumstances. 53

Phototherapy and Ultraviolet Treatment

Phototherapy is an option when psoriasis covers broader areas or does not respond adequately to topical medicines. Narrowband ultraviolet B is a commonly discussed form of phototherapy, and treatment is administered according to a planned clinical schedule. Merck identifies exposure to ultraviolet light as one component of psoriasis care, alongside topical and systemic medicines. 110

Phototherapy is not equivalent to unstructured sun exposure. Sunburn and other skin injuries can trigger psoriasis, while excessive ultraviolet exposure carries skin-related risks. A clinician determines whether phototherapy is appropriate, which body areas require treatment, and how monitoring should occur. The approach may be used alone or combined with topical or systemic therapy when clinically appropriate. 15

Oral and Injectable Systemic Medicines

Moderate-to-severe psoriasis, extensive disease, difficult locations, or inadequate response to topical treatment may lead to consideration of systemic medicines. Options identified in the research include methotrexate, cyclosporine, oral retinoids such as acitretin, apremilast, and prescription biologic therapies. These medicines act throughout the body and therefore require individualized assessment rather than routine self-selection. 210

Systemic treatment involves trade-offs involving safety, monitoring, interactions, and suitability for a person’s health profile. Because some psoriasis medicines suppress or modify immune activity, infection risk and other potential adverse effects must be weighed against expected benefits. Treatment plans may change over time if disease activity, response, side effects, or health circumstances change. 34

Biologics and Targeted Therapies

Biologic medicines are prescription therapies that target specific immune pathways involved in psoriasis. The research identifies biologics directed at tumor necrosis factor, interleukin-17, interleukin-12/23, or interleukin-23 pathways. Oral small-molecule medicines are another targeted category. These therapies have expanded the options available for people whose psoriasis is extensive, persistent, or inadequately controlled with other approaches. 210

Eligibility for a biologic or targeted medicine depends on clinical assessment, treatment history, disease burden, affected sites, joint symptoms, and relevant health conditions. The choice is not determined solely by the visible size of plaques, because high-impact locations and psoriatic arthritis can significantly alter treatment needs. Ongoing follow-up is required to assess effectiveness, tolerability, and continuing appropriateness. 34

Psoriatic Arthritis and Whole-Person Care

Up to 30% of people with psoriasis develop psoriatic arthritis, according to the Merck Professional Edition. Persistent joint pain, swelling, stiffness, or reduced range of motion should be discussed with a healthcare professional because joint disease can occur before, after, or alongside skin symptoms. Dermatologists commonly manage skin psoriasis, while rheumatologists manage psoriatic arthritis. 23

Supportive measures can complement medical treatment. Moisturizing and gentle skin care may reduce dryness and irritation, while smoking cessation, moderation of alcohol use, weight management when appropriate, and stress management may support overall disease management. These measures do not replace prescribed therapy. Psoriasis is also associated with concerns including depression, anxiety, cardiovascular disease, and metabolic syndrome, making broader health assessment relevant. 1105

Sources

1. Merck Manual Consumer Version, “Psoriasis”
2. Merck Manual Professional Edition, “Psoriasis”
3. Sharecare, “5 psoriasis treatments and how to choose the right one for you”
4. Psoriasis Canada, “Assessing Your Treatment Options”
5. UCLA Health, “Your guide to managing psoriasis”
6. National Psoriasis Foundation, “About Psoriasis”
7. American Academy of Dermatology, “Psoriasis Treatment”
8. Mayo Clinic, “Psoriasis: Diagnosis and Treatment”
9. National Health Service, “Psoriasis Treatment”
10. NCBI Bookshelf, StatPearls, “Plaque Psoriasis”